Advanced search
Publication Cover
Regenerative Medicine Volume 7, 2012 - Issue 5
Submit an article Journal homepage
265
Views
0
CrossRef citations to date
0
Altmetric
Review

From Cell Culture to a Cure: Pancreatic β-Cell Replacement Strategies for Diabetes Mellitus

Jennifer M Chhoun1 University of Minnesota, Department of Medicine, 2001 6th Street SE, Minneapolis, MN55455, USA
,
Kristin J Voltzke1 University of Minnesota, Department of Medicine, 2001 6th Street SE, Minneapolis, MN55455, USA
&
Meri T Firpo1 University of Minnesota, Department of Medicine, 2001 6th Street SE, Minneapolis, MN55455, USACorrespondence[email protected]
Pages 685-695 | Published online: 06 Sep 2012

References

  • D‘AlessioDA, VerchereCB, KahnSE et al. Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes43(12) , 1457–1461 (1994).
  • JohnsonJD, LucianiDS. Mechanisms of pancreatic beta-cell apoptosis in diabetes and its therapies. Adv. Exp. Med. Biol.654 , 447–462 (2010).
  • BrunettiA, ChiefariE, FotiD. [Perspectives on the contribution of genetics to the pathogenesis of Type 2 diabetes mellitus.] Recenti Prog. Med.102(12) , 468–475 (2011).
  • BlondeL. Benefits and risks for intensive glycemic control in patients with diabetes mellitus. Am. J. Med. Sci.343(1) , 17–20 (2012).
  • SquiffletJP, GruessnerRW, SutherlandDE. The history of pancreas transplantation: past, present and future. Acta Chir. Belg.108(3) , 367–378 (2008).
  • RichterA, LernerS, SchröppelB. Current state of combined kidney and pancreas transplantation. Blood Purif.31(1–3) , 96–101 (2011).
  • DrachenbergCB, KlassenDK, WeirMR et al. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation68(3) , 396–402 (1999).
  • SchnickelGT, BusuttilRW, LipshutzGS. Improvement in short-term pancreas transplant outcome by targeted antimicrobial therapy and refined donor selection. Am. Surg.77(10) , 1407–1411 (2011).
  • ReemtsmaK. Experimental islet cell grafting: a transplantation model. Transplant. Proc.2(4) , 513–515 (1970).
  • MatsumotoS. Autologous islet cell transplantation to prevent surgical diabetes. J. Diabetes3(4) , 328–336 (2011).
  • BerneyT, JohnsonPR. Donor pancreata: evolving approaches to organ allocation for whole pancreas versus islet transplantation. Transplantation90(3) , 238–243 (2010).
  • BalamuruganAN, LoganathanG, BellinMD et al. A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products. Transplantation93(7) , 693–702 (2012).
  • TakitaM, MatsumotoS, ShimodaM et al. Association between the secretory unit of islet transplant objects index and satisfaction with insulin therapy among insulin-dependent islet recipients. Transplant. Proc.43(9) , 3250–3255 (2011).
  • ShapiroAM, RicordiC, HeringBJ et al. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med.355(13) , 1318–1330 (2006).
  • D‘AmourKA, AgulnickAD, EliazerS, KellyOG, KroonE, BaetgeEE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol.23(12) , 1534–1541 (2005).
  • D‘AmourKA, BangAG, EliazerS et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol.24(11) , 1392–1401 (2006).
  • JiangW, ShiY, ZhaoD et al.In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res.17(4) , 333–344 (2007).
  • KroonE, MartinsonLA, KadoyaK et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol.26(4) , 443–452 (2008).
  • PhillipsBW, HentzeH, RustWL et al. Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. Stem Cells Dev.16(4) , 561–578 (2007).
  • ShimJH, KimSE, WooDH et al. Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetologia50(6) , 1228–1238 (2007).
  • TakahashiK, YamanakaS. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4) , 663–676 (2006).
  • YuJ, VodyanikMA, Smuga-OttoK et al. Induced pluripotent stem cell lines derived from human somatic cells. Science318(5858) , 1917–1920 (2007).
  • TakahashiK, OkitaK, NakagawaM, YamanakaS. Induction of pluripotent stem cells from fibroblast cultures. Nat. Protoc.2(12) , 3081–3089 (2007).
  • HiraiH, TaniT, Katoku-KikyoN et al. Radical acceleration of nuclear reprogramming by chromatin remodeling with the transactivation domain of MyoD. Stem Cells29(9) , 1349–1361 (2011).
  • AasenT, RayaA, BarreroMJ et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol.26(11) , 1276–1284 (2008).
  • FusakiN, BanH, NishiyamaA, SaekiK, HasegawaM. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn Acad. Ser. B Phys. Biol. Sci.85(8) , 348–362 (2009).
  • KimD, Kim C-H, Moon J-I et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell4(6) , 472–476 (2009).
  • YuJ, HuK, Smuga-OttoK et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science324(5928) , 797–801 (2009).
  • HuK, YuJ, SuknunthaK et al. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood117(14) , e109–e119 (2011).
  • JiaF, WilsonKD, SunN et al. A nonviral minicircle vector for deriving human iPS cells. Nat. Methods7(3) , 197–199 (2010).
  • WarrenL, ManosPD, AhfeldtT et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell7(5) , 618–630 (2010).
  • Kanai-AzumaM, KanaiY, GadJM et al. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development129(10) , 2367–2379 (2002).
  • StaffordD, PrinceVE. Retinoic acid signaling is required for a critical early step in zebrafish pancreatic development. Curr. Biol.12(14) , 1215–1220 (2002).
  • StaffordD, HornbruchA, MuellerPR, PrinceVE. A conserved role for retinoid signaling in vertebrate pancreas development. Dev. Genes Evol.214(9) , 432–441 (2004).
  • KimSK, MeltonDA. Pancreas development is promoted by cyclopamine, a hedgehog signaling inhibitor. Proc. Natl Acad. Sci. USA95(22) , 13036–13041 (1998).
  • BurnsCJ. Stem cell therapy for diabetes: do we need to make beta cells? J. Endocrinol.183(3) , 437–443 (2004).
  • FernandesAM, FernandesTG, DiogoMM, Da Silva CL, Henrique D, Cabral JMS. Mouse embryonic stem cell expansion in a microcarrier-based stirred culture system. J. Biotechnol.132(2) , 227–236 (2007).
  • Fernandes-PlatzgummerA, DiogoMM, BaptistaRP, SilvaCLD, CabralJMS. Scale-up of mouse embryonic stem cell expansion in stirred bioreactors. Biotechnol. Prog.27(5) , 1421–1432 (2011).
  • FernandesAM, MarinhoPA, SartoreRC et al. Successful scale-up of human embryonic stem cell production in a stirred microcarrier culture system. Braz. J. Med. Biol. Res.42(6) , 515–522 (2009).
  • SantosFD, AndradePZ, AbecasisMM et al. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. Tissue Eng. Part C Methods17(12) , 1201–1210 (2011).
  • ShafaM, KrawetzR, ZhangY et al. Impact of stirred suspension bioreactor culture on the differentiation of murine embryonic stem cells into cardiomyocytes. BMC Cell Biol.12(1) , 53 (2011).
  • TaianiJT, KrawetzRJ, Zur Nieden NI et al. Reduced differentiation efficiency of murine embryonic stem cells in stirred suspension bioreactors. Stem Cells Dev.19(7) , 989–998 (2010).
  • LockLT, TzanakakisES. Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng. Part A15(8) , 2051–2063 (2009).
  • WangN, AdamsG, ButteryL, FalconeFH, StolnikS. Alginate encapsulation technology supports embryonic stem cells differentiation into insulin-producing cells. J. Biotechnol.144(4) , 304–312 (2009).
  • XuC. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res.91(6) , 501–508 (2002).
  • HandgretingerR, LangP, IhmK et al. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma. Bone Marrow Transplant.29(9) , 731–736 (2002).
  • KollerMR, HananiaEG, StevensJ et al. High-throughput laser-mediated in situ cell purification with high purity and yield. Cytometry61(2) , 153–161 (2004).
  • PetersenOW, GudjonssonT, VilladsenR, BissellMJ, R⊘nnov-JessenL. Epithelial progenitor cell lines as models of normal breast morphogenesis and neoplasia. Cell Prolif.36(Suppl. 1) , 33–44 (2003).
  • SafaríkI, SafaríkováM. Use of magnetic techniques for the isolation of cells. J. Chromatogr. B Biomed. Sci. Appl.722(1–2) , 33–53 (1999).
  • ChooAB, TanHL, AngSN et al. Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells26(6) , 1454–1463 (2008).
  • LenzenS. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia51(2) , 216–226 (2008).
  • InadaA, KanamoriH, AraiH et al. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse. J. Cell. Physiol.215(2) , 383–391 (2008).
  • AlipioZ, LiaoW, RoemerEJ et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc. Natl Acad. Sci. USA107(30) , 13426–13431 (2010).
  • SaitoH, TakeuchiM, ChidaK, MiyajimaA. Generation of glucose-responsive functional islets with a three-dimensional structure from mouse fetal pancreatic cells and iPS cells in vitro. PLoS One6(12) , e28209 (2011).
  • RoepBO. Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth. Ann. NY Acad. Sci.1103(1) , 1–10 (2007).
  • Von HerrathM, NepomGT. Animal models of human Type 1 diabetes. Nat. Immunol.10(2) , 129–132 (2009).
  • ShodaLKM, YoungDL, RamanujanS et al. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity23(2) , 115–126 (2005).
  • BrehmMA, BortellR, DiiorioP et al. Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice. Diabetes59(9) , 2265–2270 (2010).
  • VerchereCB, D‘alessioDA, PalmiterRD et al. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc. Natl Acad. Sci. USA93(8) , 3492–3496 (1996).
  • ButlerAE, JangJ, GurloT, CartyMD, SoellerWC, ButlerPC. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for Type 2 diabetes. Diabetes53(6) , 1509–1516 (2004).
  • FiorinaP, ShapiroAMJ, RicordiC, SecchiA. The clinical impact of islet transplantation. Am. J. Transplant.8(10) , 1990–1997 (2008).
  • MayhewCN, WellsJM. Converting human pluripotent stem cells into beta-cells: recent advances and future challenges. Curr. Opin. Organ Transplant.15(1) , 54–60 (2010).
  • Van Der WindtDJ, EcheverriGJ, IjzermansJN, CooperDK. The choice of anatomical site for islet transplantation. Cell. Transplant17(9) , 1005–1014 (2008).
  • O‘SullivanES, VegasA, AndersonDG, WeirGC. Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr. Rev.32(6) , 827–844 (2011).
  • ZhiZ-L, Liu B, Jones PM, Pickup JC. Polysaccharide multilayer nanoencapsulation of insulin-producing beta-cells grown as pseudoislets for potential cellular delivery of insulin. Biomacromolecules11(3) , 610–616 (2010).
  • ShaoS, GaoY, XieB, XieF, LimSK, LiG. Correction of hyperglycemia in Type 1 diabetic models by transplantation of encapsulated insulin-producing cells derived from mouse embryo progenitor. J. Endocrinol.208(3) , 245–255 (2011).
  • JourdanG, DusseaultJ, BenhamouPY, RosenbergL, HalléJP. Co-encapsulation of bioengineered IGF-II-producing cells and pancreatic islets: effect on beta-cell survival. Gene Ther.18(6) , 539–545 (2011).
  • IlievaA, YuanS, WangRN, AgapitosD, HillDJ, RosenbergL. Pancreatic islet cell survival following islet isolation: the role of cellular interactions in the pancreas. J. Endocrinol.161(3) , 357–364 (1999).
  • RobitailleR. Insulin-like growth factor II allows prolonged blood glucose normalization with a reduced islet cell mass transplantation. Endocrinology144(7) , 3037–3045 (2003).
  • KimH, ToyofukuY, LynnFC et al. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat. Med.16(7) , 804–808 (2010).
  • SorensonRL, BreljeTC. Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm. Metab. Res.29(6) , 301–307 (1997).
  • NielsenJH, GalsgaardED, M⊘ldrupA et al. Regulation of beta-cell mass by hormones and growth factors. Diabetes50(Suppl. 1) , S25–S29 (2001).
  • ParsonsJA, BreljeTC, SorensonRL. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology130(3) , 1459–1466 (1992).
  • YechoorV, ChanL. Minireview: beta-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation. Mol. Endocrinol.24(8) , 1501–1511 (2010).
  • BaeyensL, BreuckS, LardonJ, MfopouJK, RoomanI, BouwensL. In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia48(1) , 49–57 (2004).
  • LardonJ, HuyensN, RoomanI, BouwensL. Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas. Virchows Arch.444(1) , 61–65 (2004).
  • ZhaoM, AmielSA, ChristieMR, RelaM, HeatonN, HuangGC. Insulin-producing cells derived from human pancreatic non-endocrine cell cultures reverse streptozotocin-induced hyperglycaemia in mice. Diabetologia48(10) , 2051–2061 (2005).
  • LeeJ, WenJ, ParkJY, Kim S-A, Lee EJ, Song SY. Reversal of diabetes in rats using GLP-1-expressing adult pancreatic duct-like precursor cells transformed from acinar to ductal cells. Stem Cells Dev.18(7) , 991–1002 (2009).
  • ZhouQ, BrownJ, KanarekA, RajagopalJ, MeltonDA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature455(7213) , 627–632 (2008).
  • YechoorV, LiuV, EspirituC et al. Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev. Cell16(3) , 358–373 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.